Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study

Lifestyle therapy is an integral part of type 2 diabetes (T2D) management, but there remains no consensus on an optimal diet. The objective of this study is to evaluate the efficacy of therapeutic fasting as a treatment for T2D. This case follows a male T2D patient treated at the Intensive Dietary M...

Full description

Bibliographic Details
Main Authors: Michael Ku, Megan J. Ramos, Jason Fung
Format: Article
Language:English
Published: AOSIS 2017-12-01
Series:Journal of Insulin Resistance
Subjects:
Online Access:https://insulinresistance.org/index.php/jir/article/view/31
id doaj-43c0afe896114166adaaef88a3bb3600
record_format Article
spelling doaj-43c0afe896114166adaaef88a3bb36002020-11-25T00:11:36ZengAOSISJournal of Insulin Resistance2412-27852519-75332017-12-0121e1e510.4102/jir.v2i1.3112Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case studyMichael Ku0Megan J. Ramos1Jason Fung2Department of Psychology,Neuroscience and Behaviour, Faculty of Science, McMaster UniversityIntensive Dietary Management ClinicDepartment of Medicine, Scarborough General HospitalLifestyle therapy is an integral part of type 2 diabetes (T2D) management, but there remains no consensus on an optimal diet. The objective of this study is to evaluate the efficacy of therapeutic fasting as a treatment for T2D. This case follows a male T2D patient treated at the Intensive Dietary Management Clinic in Scarborough, Ontario, over a 4-month period. The patient’s initial fasting regimen consisted of a 24-h fast, three times a week. Over the course of treatment, the patient gradually extended his fasting period, eventually fasting for 42 h, two to three times a week. By the end of treatment, the patient’s weight was reduced by 17.8% and his waist circumference was reduced by 11.0%. In addition, the patient’s glycated haemoglobin levels decreased from 7.7% to 7.2%, and he was able to completely discontinue his insulin treatment, despite over a decade of insulin usage. The patient did not find it difficult to adhere to the fasting schedule and did not experience any hypoglycaemic episodes or other significant adverse effects. These observations suggest that therapeutic fasting may be a viable treatment option for T2D patients.https://insulinresistance.org/index.php/jir/article/view/31type 2 diabetestherapeutic fastingintermittent fasting
collection DOAJ
language English
format Article
sources DOAJ
author Michael Ku
Megan J. Ramos
Jason Fung
spellingShingle Michael Ku
Megan J. Ramos
Jason Fung
Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study
Journal of Insulin Resistance
type 2 diabetes
therapeutic fasting
intermittent fasting
author_facet Michael Ku
Megan J. Ramos
Jason Fung
author_sort Michael Ku
title Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study
title_short Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study
title_full Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study
title_fullStr Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study
title_full_unstemmed Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study
title_sort therapeutic fasting as a potential effective treatment for type 2 diabetes: a 4-month case study
publisher AOSIS
series Journal of Insulin Resistance
issn 2412-2785
2519-7533
publishDate 2017-12-01
description Lifestyle therapy is an integral part of type 2 diabetes (T2D) management, but there remains no consensus on an optimal diet. The objective of this study is to evaluate the efficacy of therapeutic fasting as a treatment for T2D. This case follows a male T2D patient treated at the Intensive Dietary Management Clinic in Scarborough, Ontario, over a 4-month period. The patient’s initial fasting regimen consisted of a 24-h fast, three times a week. Over the course of treatment, the patient gradually extended his fasting period, eventually fasting for 42 h, two to three times a week. By the end of treatment, the patient’s weight was reduced by 17.8% and his waist circumference was reduced by 11.0%. In addition, the patient’s glycated haemoglobin levels decreased from 7.7% to 7.2%, and he was able to completely discontinue his insulin treatment, despite over a decade of insulin usage. The patient did not find it difficult to adhere to the fasting schedule and did not experience any hypoglycaemic episodes or other significant adverse effects. These observations suggest that therapeutic fasting may be a viable treatment option for T2D patients.
topic type 2 diabetes
therapeutic fasting
intermittent fasting
url https://insulinresistance.org/index.php/jir/article/view/31
work_keys_str_mv AT michaelku therapeuticfastingasapotentialeffectivetreatmentfortype2diabetesa4monthcasestudy
AT meganjramos therapeuticfastingasapotentialeffectivetreatmentfortype2diabetesa4monthcasestudy
AT jasonfung therapeuticfastingasapotentialeffectivetreatmentfortype2diabetesa4monthcasestudy
_version_ 1725403169099350016